Results 161-180 of 1,038 for hpv

Seanad: An tOrd Gnó - Order of Business (4 Nov 2021)

Martin Conway: ...identified as one of the most influential women in sport in Ireland. It is a tribute to what she and the organisation have achieved, and I congratulate her on that. I want to raise the fact the HPV vaccine has been shown to lead to a 90% reduction in cervical cancer. It is a tribute to Laura Brennan and a tribute to the people who have campaigned tirelessly for the HPV vaccine to be...

Written Answers — Department of Health: Vaccination Programme (2 Mar 2017) See 5 other results from this answer

Simon Harris: ...appropriate information is taken into account when deciding to make changes to the State's immunisation programmes. Each year in Ireland around 300 women are diagnosed with cervical cancer. The HPV vaccine protects against two high risk types of HPV (16 & 18) that cause 73% of all cervical cancers. Vaccinated women and girls will still be at risk from other high risk types of...

Written Answers — Vaccination Programme: Vaccination Programme (8 Jul 2010) See 2 other results from this answer

Mary Harney: I propose to take Questions Nos. 261 and 262 together. The National Immunisation Advisory Committee (NIAC) undertook a scientific assessment of the public health value of HPV following a request from my Department. NIAC and the National Cancer Screening Service (NCSS) agreed that this work needed to be complemented by a study of the cost effectiveness of the vaccine in the current Irish...

Written Answers — Cancer Screening Programme: Cancer Screening Programme (23 Feb 2010)

Mary Harney: Infection with Human Papillomavirus (HPV) is the main cause of cervical cancer. HPV is transmitted mainly through sexual contact. For this reason and having regard to the reports by the Health Information and Quality Authority and from the National Immunisation Advisory Committee and based on the best medical advice available to me that HPV vaccine does have the potential to play an important...

Written Answers — Department of Health: Vaccination Programme (6 Sep 2019)

Simon Harris: ...in Ireland and to keep abreast of changes in the patterns of disease. Therefore, the immunisation schedule will continue to be amended over time. As you are aware, NIAC recommended that the HPV vaccine should also be given to boys. The ages at which vaccines are recommended in the immunisation schedule are chosen by NIAC in order to give each child the best possible protection...

Topical Issue Debate: Vaccination Programme (3 Nov 2015) See 2 other results from this debate

Leo Varadkar: ...me an opportunity to address the House on this issue. I want to acknowledge the concerns of families who believe their daughters have experienced adverse reactions and health issues after receiving the HPV vaccine. As the House will know, the vaccine protects against two high-risk types of HPV that cause 73% of all cervical cancers. The link between HPV and cervical cancer is as well...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018) See 5 other results from this debate

Mr. Damien McCallion: We secured extra resources for HPV testing from the United Kingdom and other places to try to ensure we would minimise the risk. There is still an overlap with some of the people involved in managing the backlog in the current system also involved in the HPV testing project. There is still an overlap in that some of the people that are involved in managing the backlog...

Written Answers — Department of Health: Vaccination Programme (17 Feb 2021)

Stephen Donnelly: ...of new vaccines in Ireland and to keep abreast of changes in the patterns of disease. Therefore, the immunisation schedule will continue to be amended over time. In 2009, the NIAC recommended HPV (human papillomavirus) vaccination for all 12 to 13 year old girls to reduce their risk of developing cervical cancer when they are adults. In September 2010, the HPV vaccination programme was...

Written Answers — Vaccination Programme: Vaccination Programme (21 Sep 2011)

James Reilly: The HPV vaccination programme has been operational in second level schools since 2010 for girls in first year and second year. A catch-up programme for the vaccination of all girls in secondary schools, as committed for action in the first 100 days of the Government's term commenced last week This will be repeated for the following two years in September 2012 and 2013 and will result in...

Written Answers — Department of Health: Vaccination Programme (15 Nov 2017) See 1 other result from this answer

Simon Harris: I am aware of claims of an association between HPV vaccination and a number of conditions experienced by a group of young women. An illness that occurs around the time a vaccine is given and is already known to be common in adolescence does not imply the vaccine caused the problem. It appears that some girls first suffered symptoms around the time they received the HPV vaccine, and...

Written Answers — Department of Health: Vaccination Programme (22 Oct 2015)

Leo Varadkar: I am aware of and have been monitoring the situation in relation to the human papilloma virus (HPV) vaccine. The HPV vaccine protects women from developing cervical cancer. The vaccine is available free of charge from the HSE for all girls in 1st year of secondary school. This is in accordance with the recommendation received from the National Immunisation Advisory Committee. In Ireland,...

Written Answers — Department of Health: Cancer Screening Programmes (5 Feb 2019)

Simon Harris: ...and governance, laboratory services and procurement, open disclosure, cancer registration, other screening programmes and resolution. As the Deputy will be aware, I have also asked the HSE to introduce HPV testing as the primary screening method for the prevention of cervical cancer. The HPV test is a more accurate testing mechanism than liquid-based cytology, which is the current...

Written Answers — Department of Children and Youth Affairs: Vaccination Programme (5 Nov 2015)

Leo Varadkar: In Ireland, the Health Products Regulatory Authority (HPRA) is the regulatory authority for medicines in Ireland. There are 2 licensed HPV vaccines available in Ireland (Gardasil®and Cervarix®). Gardasil®is the vaccine used by the HSE in the School Immunisation Programme. The vaccine protects against two high risk types of HPV (16 & 18) that cause 73% of all cervical...

Written Answers — Department of Health: Vaccination Programme (3 Nov 2015)

Leo Varadkar: In Ireland, the Health Products Regulatory Authority (HPRA) is the regulatory authority for medicines in Ireland. There are 2 licensed HPV vaccines available in Ireland (Gardasil®and Cervarix®). Gardasil®is the vaccine used by the HSE in the School Immunisation Programme. The vaccine protects against two high risk types of HPV (16 & 18) that cause 73% of all cervical...

Ceisteanna ar Reachtaíocht a Gealladh - Questions on Promised Legislation (13 Feb 2019)

Micheál Martin: The Government announced that the new HPV test - I may have inadvertently called it the "HPV vaccine" earlier - would be available last September, and that the programme relating to it would eventually replace the current programme. Unfortunately, this target was missed and it was then set for January. However, January has come and gone and it has not been announced. There does not appear...

Written Answers — Department of Health: Vaccination Programme (26 Nov 2019)

Simon Harris: ...for vaccine trials. The Health Products Regulatory Authority (HPRA) is responsible for monitoring the safety and quality of all medicines including vaccines that are licensed in Ireland. All HPV vaccines available in the EU are authorised by the European Medicines Agency (EMA). The HPRA has advised that the specific HPV vaccine trial has not been identified in this query....

Written Answers — Department of Health: Vaccination Programme (22 Sep 2015)

Leo Varadkar: ...of the safest and most cost-effective of health care interventions. International studies and scientific assessments suggest that the best way to prevent most disease due to human papillomavirus (HPV) is to vaccinate as many girls and women as possible. The HPV vaccine protects girls from developing cervical cancer when they are adults. It is available free of charge from the HSE for...

Written Answers — Department of Health: Vaccination Programme (19 Oct 2016) See 1 other result from this answer

Simon Harris: ...health. The committee's recommendations are informed by public health advice and international best practice. Each year in Ireland around 300 women are diagnosed with cervical cancer. The HPV vaccine protects against two high risk types of HPV (16 & 18) that cause 73% of all cervical cancers. Vaccinated women and girls will still be at risk from other high risk types of HPV...

Written Answers — Department of Health: Vaccination Programme (20 Apr 2016)

Leo Varadkar: ...in a number of specialties including infectious diseases, paediatrics and public health. The committee's recommendations are informed by public health advice and international best practice. The HPV vaccine protects girls from developing cervical cancer when they are adults. It is available free of charge from the HSE for all girls in 1st year of secondary school and over 200,000 girls...

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme Update: Discussion (13 Feb 2019) See 6 other results from this debate

Stephen Donnelly: I thank the witnesses for their time today and for the opening statements. The HPV test was spoken of with much interest last year. It represents a higher level of detection and, therefore, patient safety. The Minister sought to have the HPV test implemented last September. When that deadline was missed, I believe the Minister suggested having it live in January. It is now February. I...